未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a combined analysis of a phase Ib and a phase II studyKN026(一种双特异性抗HER2抗体)与KN046(一种抗CTLA4/PD-L1抗体)联合治疗晚期HER2阳性非乳腺癌患者的有效性与安全性:一项Ib期和II期研究的合并分析
Liu, Dan; Gong, Jifang; Li, Jian; Qi, Changsong; Niu, Zuoxing; Liu, Bo; Peng, Zhi; Luo, Suxia; Wang, Xicheng; Wang, Yakun; Zhao, Rusen; Chen, Lilin; Deng, Ting; Li, Zhen; Chen, Lei; Fang, Meimei; Yang, Hongwei; Lu, Linzhi; Zhang, Yanming; Kang, Fengling; Xu, Ting; Zhang, Xiaotian
分享
收藏
分享
收藏
分享
收藏
分享
收藏Visible-light-responsive perovskite manganate epitaxial film: Driven role of oxygen vacancies for photoelectric effect
Zhao, Guangyuan; Yang, Jiacheng; Deng, Ting; Li, Jie; Li, Xiaoqian; Huang, Heyan; Guo, Baogang; Hu, Hailong; Zheng, Kui; Liu, Haifeng
分享
收藏Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer
Liu, Rui; Ji, Zhi; Wang, Xia; Xin, Jiaqi; Zhu, Lila; Ge, Shaohua; Zhang, Le; Bai, Ming; Ning, Tao; Yang, Yuchong; Li, Hongli; Deng, Ting; Ba, Yi
分享
收藏
分享
收藏
分享
收藏